Skip to main content
Top

Inflammation

Issue 3-4/2007

Content (6 Articles)

Ozone Therapy in Induced Endotoxemic Shock. II. The Effect of Ozone Therapy Upon Selected Histochemical Reactions in Organs of Rats in Endotoxemic Shock

Paweł Madej, Andrzej Plewka, Janusz A. Madej, Danuta Plewka, Wojciech Mroczka, Krzysztof Wilk, Zuzanna Dobrosz

A Low Molecular Weight Proinflammatory Factor from Rat Spleen Lymphocytes. Isolation and Partial Characterization

Suzelei de Castro França, Maria Madalena Correa, Ieda Regina dos Santos Schivo, João Garcia Leme, José Roberto Giglio

Anti-Inflammation Role for Mesenchymal Stem Cells Transplantation in Myocardial Infarction

Jun Guo, Guo-sheng Lin, Cui-yu Bao, Zhi-min Hu, Ming-yan Hu

Effect of T0901317 on Hepatic Proinflammatory Gene Expression in ApoE−/− Mice Fed a High-fat/high-cholesterol Diet

Xiaoyan Dai, Xiang Ou, Xinrui Hao, Dongli Cao, Yaling Tang, Yanwei Hu, Xiaoxu Li, Chaoke Tang

High Macrophage Migration Inhibitory Factor Levels in Disseminated Intravascular Coagulation Patients with Systemic Inflammation

Satoshi Gando, Atsushi Sawamura, Mineji Hayakawa, Hirokatsu Hoshino, Nobuhiko Kubota, Jun Nishihira

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine